We are live on ! Find out more
BIOSW

BioPlus Acquisition Corp. Warrants
BIOSW

Delisted

BIOSW was delisted on the 6th of October, 2023.

Back to rankings

44 hedge funds and large institutions have $1.35M invested in BioPlus Acquisition Corp. Warrants in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

2% more funds holding

Funds holding: 43 → 44 (+1)

43% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 7

76% less capital invested

Capital invested by funds: $5.67M → $1.35M (-$4.33M)

Holders
44
Holders Change
+1
Holders Change %
+2.33%
% of All Funds
0.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
7
Closed
2
Calls
$866K
Puts
–
Net Calls
+$866K
Net Calls Change
-$1.14M

Top Buyers

Rank Fund Capital Flow
1
SFM
Spartan Fund Management
Canada
+$44.7K
2
CAC
Cowen and Company
New York
+$33.3K
3
HIM
HGC Investment Management
Ontario, Canada
+$20.7K
4
SCM
Shaolin Capital Management
Florida
+$10.3K
5
Walleye Capital
Walleye Capital
New York
+$6.62K

Top Sellers

Rank Fund Capital Flow
1
MP
Mangrove Partners
Connecticut
-$3.56M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$6.43K
3
KL
KIM LLC
Kansas
-$3.13K
4
CS
Clear Street
New York
-$1.31K
5
CSS
Cubist Systematic Strategies
Connecticut
-$952
Name Holding Trade Value Shares
Change 		Change in
Stake
PC
1
Periscope Capital
Ontario, Canada
$122K – – –
SCM
2
Saba Capital Management
New York
$105K – – –
PAMP
3
Polar Asset Management Partners
Ontario, Canada
$88.7K – – –
SCM
4
Shaolin Capital Management
Florida
$74K +$10.3K +99,300 +25%
Calamos Advisors
5
Calamos Advisors
Illinois
$68.3K – – –
LA
6
Linden Advisors
New York
$68.3K – – –
CAC
7
Cowen and Company
New York
$67.9K +$33.3K +321,287 +230%
Goldman Sachs
8
Goldman Sachs
New York
$53.1K – – –
MI
9
MMCAP International
Cayman Islands
$47.9K – – –
AA
10
AQR Arbitrage
Connecticut
$43.4K -$260 -2,514 -0.8%
D.E. Shaw & Co
11
D.E. Shaw & Co
New York
$39.6K – – –
CSS
12
Cubist Systematic Strategies
Connecticut
$38.4K -$952 -9,200 -3%
CF
13
Cantor Fitzgerald
New York
$36.9K – – –
TCA
14
Taconic Capital Advisors
New York
$36.3K – – –
SC
15
Sculptor Capital
New York
$33.7K – – –
DKCM
16
Davidson Kempner Capital Management
New York
$32.2K – – –
KL
17
KIM LLC
Kansas
$30K -$3.13K -30,200 -12%
QGA
18
Q Global Advisors
Texas
$29K – – –
RCM
19
Radcliffe Capital Management
Pennsylvania
$27.9K – – –
HIM
20
HGC Investment Management
Ontario, Canada
$26K +$20.7K +200,000 New
UOC
21
UBS O'Connor
Illinois
$25.4K -$425 -4,104 -2%
HCM
22
Highbridge Capital Management
New York
$22.2K – – –
SFM
23
Spartan Fund Management
Canada
$20.9K +$44.7K +432,159 +576%
CS
24
Clear Street
New York
$20.4K -$1.31K -12,664 -8%
ACM
25
Atalaya Capital Management
New York
$18.8K – – –
1
2

BIOSW Hedge Fund Activity: Q2 2023 in Review

44 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in BioPlus Acquisition Corp. Warrants (BIOSW) for Q2 2023, worth a combined $1.35M — down 76% from $5.67M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new BIOSW positions and 2 closed out — a net gain of 2 holders — while 4 added to existing stakes and 7 trimmed.

The largest buyer was Spartan Fund Management, adding an estimated $44.7K. The largest seller was Mangrove Partners, exiting entirely with an estimated $3.56M sold.

  • 44 institutional investors held BioPlus Acquisition Corp. Warrants (BIOSW) as of Q2 2023, up from 43 in Q1 2023.
  • Funds reported $1.35M of BioPlus Acquisition Corp. Warrants stock for Q2 2023, down 76% quarter-over-quarter.
  • 4 funds opened new BioPlus Acquisition Corp. Warrants positions in Q2 2023 and 2 closed out, a net change of +2 holders.
  • The largest BioPlus Acquisition Corp. Warrants buyer in Q2 2023 was Spartan Fund Management, an estimated $44.7K added.
  • The largest BioPlus Acquisition Corp. Warrants seller in Q2 2023 was Mangrove Partners, an estimated $3.56M sold.

Based on aggregated 13F filings for Q2 2023.